Cdc45 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdc45 monoclonal antibodies for research in cell cycle regulation and DNA replication. Validated applications include western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdc45 plays a significant role in the initiation of DNA replication, acting as a part of the pre-replicative complex. The proper function of Cdc45 is essential for maintaining genomic stability and ensuring accurate cell division. Dysregulation of Cdc45 has been implicated in various cancers, highlighting its importance in cancer biology and therapeutic development. Understanding Cdc45's role in cell cycle regulation provides valuable insights into fundamental biological processes. Research using Cdc45 monoclonal antibodies continues to reveal new aspects of DNA replication mechanisms. The high specificity of Santa Cruz Biotechnology monoclonal antibodies enables researchers worldwide to advance scientific understanding of cell cycle dynamics and their implications in disease.